|

TL-895 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Telios Pharma, Inc.1

Indications

  • Indolent Systemic Mastocytosis1
  • Myelofibrosis1
  • Cancer1

Aurora, Colorado1 trial

Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

University of Colorado - Aurora Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.